Marc Voigt
Company: Immutep
Job title: Chief Executive Officer
Seminars:
Opening Remarks: Reviewing the Past 12 Months of LAG-3 Therapeutic Development 9:00 am
Major LAG-3 related developments in the past 12 months by the most relevant players BMS validating LAG-3 at ASCO 2021 and other recent relevant developments What to expect in the coming 12 months?Read more
day: Day One